Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Radiation pneumonitis Leukemia Gastritis Myelosuppression 2. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Medullary thyroid carcinoma Polycythemia vera Pain in bony metastases Dyspnea in lung Ca 3. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Radioimmunotherapy. Radiation therapy. Antibody therapy. Radiochemotherapy. 4. Which of the following property of radiation is principally used in the treatment of tumors? Fluorescent effect Chemical effect Biologic effect Photographic effect 5. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Performing pulmonary function tests A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Reviewing potential interfering medications Blocking thyroid uptake of free radioiodine 6. Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are: Metronidazole and Propranolol Metronidazole and Propylthiouracil Methimazole and Propranolol Methimazole and Propylthiouracil 7. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Radiation therapy. Chemotherapy. Fine needle aspiration biopsy. Surgical removal. 8. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: Never. After 6 months. After 3 months. With the birth of another child. 9. Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy? Sm-153 Sr-89 P-32 Ra-223 10. Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is: Hyperthyroidism Thyroid carcinoma Hypothyroidism Thyroiditis 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-03-30T09:35:30+03:00March 30th, 2021| Share This Post With Others! FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. Leave a ReplyCancel reply
Leave a Reply